Monoclonal Antibodies for COVID-19

Available at COVID-19 Infusion Center

Baxter Regional can provide monoclonal antibodies for treatment of COVID-19 for patients who meet certain criteria. For more information, call the Baxter Regional COVID-19 Infusion Center at (870) 508-3010.

In November, 2020, the U.S. Food and Drug Administration issued an Emergency Use Authorization to allow the use of monoclonal antibodies for the treatment of mild to moderate symptoms of COVID-19 in adults and pediatric patients.

Monoclonal antibodies are laboratory-made proteins that mimic your immune system’s ability to fight off harmful viruses. Bamlanivimab and casirivimab + imdevimab are monoclonal antibodies that are specifically designed to protect against the spike protein of COVID-19. These proteins are designed to stop the virus from entering the human cells.

Source: Arkansas Department of Health

Who can get this treatment?

This monoclonal antibodies treatment is for non-hospitalized COVID-19 patients with mild to moderate symptoms with less than 10 days since symptom onset in one of the following high-risk categories.

Age 12 to 17 AND have any of the following:

High BMI
Sickle cell disease
Heart disease
Neurodevelopment disorders
A medical related dependence
Chronic respiratory diseases
Asthma

Age 55 to 64 AND have any of the following:

Cardiovascular disease
Hypertension
Chronic respiratory diseases
COPD

Age 12 or older AND have any of the following:

Chronic kidney
disease
BMI of 35 or
greater
Diabetes
Immunosuppressive
disease

These medications are NOT approved for use in patients who are hospitalized due to COVID-19 or require oxygen therapy. Benefits of treatment have not been observed in patients hospitalized due to COVID-19. Monoclonal antibodies may be associated with worse clinical outcomes when given to patients with COVID-19 requiring oxygen ventilation. Individual administration sites may have additional criteria for use of these monoclonal antibody therapies in patients.

For more information about monoclonal antibodies for treatment of COVID-19, contact your primary care provider or the Baxter Regional COVID-19 Infusion Center at (870) 508-3010.

Download Monoclonal Antibodies Information